Guselkumab was more effective than secukinumab in patients with plaque psoriasis and the subset of patients with self-reported PsA in the randomised, double-blind, head-to-head comparison study ECLIPSE over 1 year - Merola, JF; Li, S; Hsu, M-C; Karyekar, C; Gorecki, PC; Flavin, S; Randazzo, B; Coates, LC (Oxford University Press, 2020)